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Regulator of G-protein signaling (RGS) proteins accelerate
GTP hydrolysis by heterotrimeric G-protein a subunits and
thus inhibit signaling by many G protein-coupled recep-
tors. Several RGS proteins have a multidomain architec-
ture that adds further complexity to their roles in cell
signaling in addition to their GTPase-accelerating activity.
RGS12 contains a tandem repeat of Ras-binding domains
but, to date, the role of this protein in Ras-mediated signal
transduction has not been reported. Here, we show that
RGS12 associates with the nerve growth factor (NGF)
receptor tyrosine kinase TrkA, activated H-Ras, B-Raf,
and MEK2 and facilitates their coordinated signaling to
prolonged ERK activation. RGS12 is required for NGF-
mediated neurite outgrowth of PC12 cells, but not out-
growth stimulated by basic fibroblast growth factor.
siRNA-mediated knockdown of RGS12 expression also
inhibits NGF-induced axonal growth in dissociated cul-
tures of primary dorsal root ganglia neurons. These data
suggest that RGS12 may play a critical, and receptor-
selective, role in coordinating Ras-dependent signals that
are required for promoting and/or maintaining neuronal
differentiation.
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Introduction
Extracellular stimuli such as neurotransmitters, hormones,
odorants and light are recognized by G protein-coupled
receptors (GPCRs), one of the most abundant and diverse
protein families in the nervous system (Davies et al, 2002b).
Intercellular communication via G-protein-mediated signal-
ing pathways in the nervous system is crucial for normal
brain development and regulation of adult neural processes
(Davies et al, 2002b). Thus, defining the molecular
determinants that control GPCR signaling is important to
understanding normal development and physiology of the
nervous system and the pathophysiology of nervous system-
related disorders.
One level of regulation of GPCR signaling is mediated
by ‘regulators of G-protein signaling’ (RGS) proteins that
accelerate Ga GTP hydrolysis and inhibit signaling by many
GPCRs (Ross and Wilkie, 2000). For example, mice lacking
RGS9 show enhanced responses to photonic stimulation and
morphine administration, suggesting that RGS9 is a potent
negative regulator of both rhodopsin and opioid receptor
signal transduction in vivo (Chen et al, 2000; Zachariou
et al, 2003). In general, however, contributions by RGS
proteins to physiological control of specific receptor signaling
cascades are only now being elucidated. Multidomain RGS
proteins add further complexity to the potential signaling
roles played by RGS proteins in addition to their GTPase-
accelerating activity (reviewed in Ross and Wilkie, 2000;
Siderovski and Willard, 2005).
RGS12 is an example of a multidomain RGS protein with
numerous signaling regulatory elements. In addition to a
central RGS domain, RGS12 contains a PDZ (PSD-95/Discs-
large/ZO-1 homology) domain, a phosphotyrosine-binding
(PTB) domain, tandem Ras-binding domains (RBDs), and
a GoLoco (Gai/o-Loco) interaction motif (Ponting, 1999;
Siderovski et al, 1999). The PTB domain recruits RGS12 in
a phosphotyrosine-dependent manner to the SNARE-binding
region of the Cav2.2 calcium channel (Richman et al, 2005),
thereby determining the rate of desensitization of GABAB
receptor-mediated calcium current inhibition in dorsal root
ganglia (DRG) neurons (Schiff et al, 2000). Little is known
about the in vivo function of other domains within mamma-
lian RGS12. Recently, we examined RGS12 expression
patterns during mouse development. Full-length RGS12 is
expressed predominantly in trigeminal and DRG neurons and
muscle in the E14.5 embryonic mouse (Martin-McCaffrey
et al, 2005), suggesting a role for mammalian RGS12 in
myo- and neurogenesis.
Loco, the Drosophila RGS12 ortholog, is essential for
multiple processes in fly development, including dorsal/
ventral axis formation, neuroblast asymmetric cell division,
and nurse cell dumping (Pathirana et al, 2001; Yu et al, 2005).
loco is expressed in lateral glial cells in the developing
embryonic central nervous system and required for correct
glial cell differentiation (Granderath et al, 1999). Normal
glial–glial cell contacts are absent in loco-deficient flies,
resulting in a loss of the blood–brain barrier and subsequent
gross locomotor defects in surviving mutants. Recently, Loco,
the GPCR Moody, and the Ga subunits Gai and Gao were
found to be expressed in surface glia; these four proteins are
thought to act as part of a common signaling pathway critical
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for blood–brain barrier formation (Bainton et al, 2005;
Schwabe et al, 2005).
The requirement for Loco in glial cell development and
normal locomotion suggests that mammalian RGS12 may
also play a critical role in glial cell differentiation. Here,
we demonstrate that RGS12 facilitates formation of a Ras/
Raf/MEK/ERK multiprotein complex, suggesting a function
as a scaffold for the extracellular signal-regulated kinase
(ERK) mitogen-activated protein kinase (MAPK) cascade.
Furthermore, RGS12 interacts with the nerve growth factor
(NGF) receptor TrkA, and small interfering RNA (siRNA)-
mediated downregulation of endogenous RGS12 selectively
inhibits NGF-induced neuritogenesis of PC12 cells and axonal
growth of embryonic DRG neurons. These results suggest that
RGS12 may function in promoting a differentiated phenotype
by organizing a TrkA, Ras, Raf, MEK, and ERK signal trans-
duction complex in vivo.
Results
RGS12 interacts with MAPK cascade components
Beyond two Gai interaction domains (an RGS domain and a
C-terminal GoLoco motif), RGS12 has additional protein
motifs found in signaling adaptors, scaffolds, and effectors
(Figure 1A): N-terminal PDZ and PTB domains and a tandem
repeat of RBDs (Snow et al, 1998; Schiff et al, 2000; Kimple
et al, 2001). To identify additional RGS12 interactors,
yeast two-hybrid screens of mouse embryo and brain cDNA
libraries were performed using the PDZ/PTB domains and an
internal span including the RGS domain and tandem RBDs
(Figure 1A). Two interactors from the mouse brain library
were obtained with the N-terminal bait and validated as
bait specific (Supplementary Figure S1): the C-terminal tail
of mouse SAPAP3 (Welch et al, 2004) and the C-terminal tail
of MEK2, a middle-tier protein kinase (MAP2K) within the
ERK cascade (Johnson and Lapadat, 2002).
Both SAPAP3 and MEK2 end in canonical class I PDZ-
binding targets (SAPAP3: -Q-T-R-L-COOH; MEK2: -R-T-A-V-
COOH), suggesting that both interactors bind the PDZ
domain. The RGS12 PDZ domain is known to recognize
class I PDZ-binding targets ending in Thr-x-[Leu/Val]-COOH
(Snow et al, 1998). Biosensor studies indicated that the final
16 amino-acids (aa) of MEK2 were sufficient to bind directly
to the RGS12 PDZ domain in vitro (Supplementary Figure
S2). The interaction with MEK2 was specific for the PDZ
domain of RGS12, as co-immunoprecipitation was only seen
between full-length MEK2 and protein fragments containing
the RGS12 PDZ domain (Figure 1B); neither the first PDZ
domain of the Drosophila scaffold InaD nor the PTB domain
of mouse Numb were capable of co-immunoprecipitating
MEK2. RGS12 selectively interacts with MEK2, and not
other MAP2K members, in cell co-immunoprecipitations
(data not shown).
A separate yeast two-hybrid screen using a fragment from
the RGS domain to the second RBD (Supplementary Figure
S1) identified a fragment of A-Raf (aa 36–153) that spans the
RBD and cysteine-rich C1 (or ‘CRD’) domains N-terminal
to its kinase domain (Huleihel et al, 1986). Subsequent co-
immunoprecipitation studies showed that full-length A-Raf
and B-Raf (Figure 1C and D), but not c-Raf-1 (Supplementary
Figure S3), associate with RGS12; indeed, the interaction with
B-Raf is observed upon expressing a minimal RGS12 fragment
containing solely the tandem RBDs (Figure 1D). Similar to
A-Raf, residues within the B-Raf N-terminus appear to
mediate binding to RGS12, as B-Raf fragments spanning the
first 374 aa efficiently co-immunoprecipitated with full-length
RGS12 (Supplementary Figure S4).
RGS12 preferentially binds to activated H-Ras
Association of RGS12 with Raf and MEK (two tiers of the Ras-
regulated ERK cascade), coupled with the presence of two
RBDs within RGS12, led us to test whether RGS12 also
interacts directly with Ras GTPases. RBDs are found in Ras
effector proteins such as RalGDS, phosphoinositide-30 kinase,
and the Raf kinases that bind preferentially to activated Ras
GTPases (Wohlgemuth et al, 2005). Upon screening several
Ras family members, we found that RGS12 preferentially co-
immunoprecipitates with H-Ras and not K-, M-, or R-Ras. This
interaction was specific to activated H-Ras (Figure 2A and B).
In some instances, we observed binding of RGS12 to acti-
vated N-Ras (Figure 2A); however, when detected, this inter-
action was substantially weaker than that observed with
RBDs








































































































Figure 1 Components of the mitogen-activated protein kinase
(MAPK) cascade identified as RGS12 interactors. (A) RGS12 archi-
tecture. Numbering denotes amino-acid boundaries of domains
within rat RGS12. Parentheses denote baits used in yeast two-hybrid
screens against mouse embryo and brain libraries. MEK2 was
identified as a PDZ/PTB domain region interactor and A-Raf was
identified as an interactor of the central RGS/RBD domain region
(see Supplementary Figure S1). (B) HEK 293T cells were cotrans-
fected with FLAG-MEK2 and empty vector (‘mock’), or indicated
HA-tagged domain constructs. Anti-FLAG was used to immunopre-
cipitate (‘IP’) MEK2 from resultant lysates. Co-immunoprecipitating
proteins and total lysates resolved by SDS–PAGE were immuno-
blotted (‘IB’) with anti-FLAG and anti-HA antibodies. (C) HA-A-Raf
was cotransfected with empty vector or myc-RGS12 in COS-7 cells.
(D) HA-B-Raf was cotransfected with empty vector, myc-RGS12, or
the isolated tandem RBDs of RGS12 (‘12_RBDs’) in COS-7 cells. In
panels C and D, anti-myc was used to IP RGS12. Co-immunopreci-
pitating proteins and total lysates were then immunoblotted with
anti-myc and anti-HA antibodies.
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H-Ras. Association between RGS12 and active H-Ras appears
to be mediated by the tandem RBD region of RGS12
(Figure 2C). Interaction with activated H-Ras is diminished
by point mutation of histidine-995, within the first RBD of
RGS12, to leucine (Figure 2D; H995L), a position analogous
to the loss-of-function R89L mutation that abrogates c-Raf-1
binding to H-Ras (Fabian et al, 1994) (Supplementary Figure
S5). However, mutation of H995 in RGS12 does not interfere
with its interaction with B-Raf (Figure 2E), suggesting that the
RGS12(H995L) variant is properly folded. The RGS12 paralog
RGS14 is reported to interact with Rap GTPase isoforms
(Traver et al, 2004; Kiel et al, 2005; Mittal and Linder,
2006); however, no interaction of RGS12 with Rap1A,
Rap1B, or Rap2B was observed in cell co-immunoprecipita-
tions (Supplementary Figure S6).
RGS12 coordinates and enhances signaling to ERK
activation
Interactions with activated H-Ras and the first two tiers of the
Ras-regulated ERK signaling cascade suggests a role for
RGS12 as a MAPK scaffold facilitating receptor signaling to
ERK activation. We previously showed that RGS12 associates
with the PDGFb receptor in an agonist-independent manner
(Sambi et al, 2006); thus, we measured endogenous PDGFbR
signaling in CHO-K1 cells (Maudsley et al, 2000) in the
presence of increasing RGS12 levels. RGS12 expression
modulated PDGF-BB-stimulated activation of ERK2 phos-
phorylation in a concentration-dependent, biphasic manner
(Figure 3A)—namely, an increase in phospho-ERK2 levels
upon low RGS12 expression, transitioning to a decrease to
phospho-ERK2 levels upon higher RGS12 expression. These
results are reminiscent of ‘combinatorial inhibition’, a hall-
mark of signaling scaffolds that arises because at low scaffold
concentrations, signaling components are in excess and for-
mation of a functional complex is likely to occur, but when
scaffold is in excess, non-functional complexes with less than
the full complement of components become more prevalent
(Bray and Lay, 1997; Levchenko et al, 2000). This biphasic
effect of RGS12 expression was selective for PDGFbR signal-
ing in CHO-K1 cells, as no inhibition of epidermal growth
factor (EGF)-mediated ERK2 activation was seen even at the
highest RGS12 expression levels (data not shown).
To investigate the interaction of RGS12 with multiple Ras/
MAPK signaling components, we coexpressed RGS12 and
activated Ras GTPases with Raf kinase isoforms A-Raf,
B-Raf, or c-Raf-1, and examined the ability of RGS12 to
bind to Ras. RGS12 does not interact with activated R-Ras
(Figure 2A); however, activated H-Ras and R-Ras both inter-
act with all three Raf isoforms (reviewed in Wittinghofer and
Herrmann, 1995). Activated R-Ras did not co-immunopreci-
pitate with RGS12 in the absence or presence of any of the
three Raf kinases (Figure 3B). In contrast, the amount of H-
Ras bound to RGS12 increased upon concomitant expression
of B-Raf, but not A-Raf or c-Raf-1 (Figure 3B), suggesting that
these binary interactions (H-Ras/RGS12, RGS12/B-Raf, and
H-Ras/B-Raf) are mutually supportive and/or a trimeric
complex of all three proteins exists.
In addition to H-Ras and B-Raf, RGS12 interacts with MEK2
(Figure 1); thus, we examined whether a complex of all four
proteins might assemble in cells. Activated H-Ras (G12V
mutant), B-Raf, and MEK2 were each detected in RGS12
immunoprecipitates upon coexpression (Figure 3C and D).
Simultaneous expression of MEK2 with either activated H-
Ras or B-Raf had no effect on the amount of H-Ras or B-Raf
that co-immunoprecipitated with RGS12 (Figure 3C). In con-
trast, coexpression of activated H-Ras enhanced the amount
of both B-Raf and MEK2 associating with RGS12 (Figure 3C).
Amounts of co-immunoprecipitating H-Ras, B-Raf, and MEK2
were additionally enhanced when all four proteins were











































































































Figure 2 RGS12 and its isolated tandem RBDs preferentially interact with activated H-Ras. (A, B) HEK 293Tcells were cotransfected with myc-
RGS12 and indicated HA-Ras plasmids. Anti-myc was used to immunoprecipitate RGS12 and anti-HA used to detect associated Ras proteins. (C)
Wild-type or activated (G12V) HA-H-Ras was coexpressed with empty vector or myc-tagged, isolated tandem RBD region of RGS12 in HEK 293T
cells. Lysates were immunoprecipitated and immunoblotted as above. (D, E) Activated (G12V) HA-H-Ras (D) or HA-B-Raf (E) was coexpressed
with empty vector, wild-type myc-RGS12 (wt), or mutant myc-RGS12 (H995L) in HEK 293T cells. Lysates were immunoprecipitated and
immunoblotted as above.
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and D). These results suggest that the binding of activated
H-Ras to RGS12 facilitates the assembly of a multiprotein
complex on RGS12 that functionally links H-Ras with the first
two tiers of the MAPK cascade (B-Raf and MEK2).
Several MAPK scaffold proteins (e.g. KSR, MP1, b-arrestin-
2; reviewed in Kolch, 2005) also form macromolecular com-
plexes with the third-tier kinase ERK. As RGS12 interacts with
activated H-Ras, B-Raf, and MEK2, we reasoned that RGS12
may also assemble a MAPK complex containing the third-tier
kinase. An interaction between RGS12 and ERK1 was not
observed when only those two proteins were coexpressed in
HEK 293T cells (Figure 3D); however, when activated H-Ras,
B-Raf, and MEK2 were also coexpressed, ERK1 co-immuno-
precipitated with RGS12 (Figure 3D). These findings further
support the hypothesis that RGS12 acts as a scaffold to
assemble multiple components of the Ras-activated MAPK
cascade.
Loss of RGS12 inhibits NGF-mediated and MAPK
cascade-dependent neuritogenesis
To define the role of RGS12 as a cellular MAPK scaffold, we
identified cell lines that express RGS12 endogenously. Rabbit
antisera against both the N-terminus and RGS domain of
RGS12 confirmed the expression of full-length RGS12 in PC12
rat pheochromocytoma cells (Supplementary Figure S7).
RGS12 co-immunoprecipitated with both endogenous H-Ras
and B-Raf in PC12 cells (Figure 4A), but not with Rap1,
suggesting that a complex of RGS12 with specific MAPK
pathway members exists between endogenous components
in PC12 cells.
NGF stimulation of the TrkA receptor causes terminal
differentiation, growth inhibition, and neurite formation in
PC12 cells (Altin et al, 1991; Ng and Shooter, 1993). NGF
induces rapid and sustained activation of both Ras and ERK,
and inhibition of either Ras or ERK blocks neurite induction
(Cowley et al, 1994). Thus, NGF-induced neurite formation is
mediated by Ras activation of the ERK MAPK cascade. To
address a possible role for RGS12 in NGF-induced neurite
formation, we employed siRNA to suppress endogenous
RGS12 expression. A pool of four duplexes efficiently reduced
RGS12 expression (Supplementary Figure S8); upon separa-
tion, each of the four siRNA oligonucleotides also reduced
expression of RGS12 (Figure 4C inset and Supplementary
Figure S8). RNAi suppression of RGS12 expression impaired
NGF-mediated neurite formation (Figure 4B and Supple-
mentary Figure S9), reducing the average length of NGF-
promoted neurites over 48 h compared with cells transfected
with non-specific siRNA (Figure 4C). These results suggest
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Figure 3 RGS12 coordinates a Ras/Raf/MEK/ERK complex and enhances signaling to ERK. (A) CHO-K1 cells with endogenous PDGFbR were
transfected with ERK2–GFP and either empty vector or increasing amounts of HA-RGS12 vector, serum-starved overnight, treated with PDGF-
BB (10 ng/ml) for 5 min, and resultant ERK2 activation determined by immunoblotting lysates with anti-phospho-ERK1/2. Densitometric
quantitation of pERK2 and total ERK2-GFP levels (bottom subpanel) generated a normalized pERK2 signal (i.e. fold activation above absence of
PDGF-BB). Error bars are standard error of the mean from three independent experiments. (B) HA-tagged, activated H-Ras (G12V) (left) or
R-Ras (G38V) (right) was cotransfected with empty vector, myc-RGS12, or myc-RGS12 plus FLAG-A-Raf, B-Raf-FLAG, or c-Raf-1-FLAG vectors
in HEK 293T cells. Anti-myc immunoprecipitates were immunoblotted for co-precipitated Ras proteins with anti-HA. Total lysates were
immunoblotted with anti-myc, anti-FLAG, and anti-HA to confirm expression. The image shown is representative of three experiments; R-Ras
interaction with RGS12 upon B-Raf or c-Raf-1 coexpression was weak and variable between experiments. (C) HEK 293T cells were transfected
with myc-RGS12, HA-B-Raf, HA-MEK2, and/or HA-H-Ras G12V as indicated. Anti-myc immunoprecipitates were immunoblotted for
co-precipitated HA-B-Raf, HA-MEK2, and HA-H-Ras GV using anti-HA antibody. Expression was confirmed by immunoblotting immuno-
precipitated proteins with anti-myc, and total lysates with anti-HA. (D) HEK 293Tcells were transfected as above but with addition of HA-ERK1
vector where indicated. Detection of expression and co-immunoprecipitation was as described above. To highlight the increase in complex
formation observed when multiple Ras/MAPK components are cotransfected in panel C, we present a lighter exposure that reveals only a faint
band representing HA-MEK2 co-immunoprecipitation with myc-RGS12. Panel D represents a darker exposure to highlight the co-immuno-
precipitation of HA-ERK1, which in turn explains the RGS12–MEK2 interaction better than panel C.
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that RGS12 positively regulates NGF signaling during PC12
cell neuritogenesis.
To establish whether the identified interaction partners
of RGS12 are also essential for NGF-mediated neurite out-
growth, we employed siRNA to suppress endogenous A-Raf,
B-Raf, and MEK2 levels (Figure 4D). Knockdown of B-Raf and
MEK2 resulted in reduced PC12 neuritogenesis upon NGF
treatment, similar to that of RGS12 knockdown (Figure 4E);
in contrast, knockdown of A-Raf did not alter average neurite
length promoted by NGF treatment. These results support the
hypothesis that RGS12 and its MAPK-cascade-binding part-
ners B-Raf and MEK2 participate in NGF-mediated neurito-
genesis and suggest that the scaffolding function of RGS12
may be important in this process.
To establish further the role of RGS12 in MAPK cascade-
dependent neuritogenesis, we examined the effect of RGS12
knockdown on PC12 neurite outgrowth stimulated by acti-
vated mutants of H-Ras (G12V; Taparowsky et al, 1982) and
B-Raf (V600E; Davies et al, 2002a). Knockdown of RGS12
impaired both H-Ras- and B-Raf-stimulated neurite formation
(Figure 4F and G), suggesting that RGS12 is an effector and
scaffold for activated H-Ras and B-Raf in PC12 cells.
Prolonged ERK activation by NGF is reduced upon
RGS12 depletion
Prolonged ERK activation promotes PC12 cell differentiation,
whereas transient ERK activation promotes PC12 growth
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Figure 4 RGS12 is critical for NGF-mediated and MAPK-dependent neurite outgrowth in PC12 cells. (A) PC12 lysates were immunoprecipi-
tated with beads alone (no Ab), or anti-H-Ras, anti-Rap-1, anti-B-Raf, or anti-RGS12 antibodies. Anti-RGS12 was used to detect associated
endogenous RGS12. (B) PC12 cells were transfected with non-specific (top) or RGS12 siRNA (bottom) for 24 h, and treated with 100 ng/ml NGF
for an additional 48 h. Images were obtained as described in Materials and methods. (C) PC12 cells were transfected, treated with NGF, and
imaged as in panel B. Neurite lengths were measured for 4100 cells per condition in three independent experiments as described in Materials
and methods. The average for each condition is represented by a black line. Median neurite length in non-specific versus RGS12 siRNA-
transfected cultures were significantly different (Po0.0001; Mann–Whitney test used given non-Gaussian distributions). Inset: PC12 cells were
transfected with non-specific (ns) or RGS12 siRNA, and lysed 24, 48, and 96 h post-transfection for immunoblotting for RGS12 and actin. (D)
PC12 cells were transfected with non-specific or (i) A-Raf-, (ii) B-Raf-, or (iii) MEK2-directed siRNA, and lysed 72 h post-transfection for
immunoblotting for expression of actin and relevant protein target. (E) PC12 cells were transfected with gene-specific siRNAs as in panel D and
resultant neurite length statistics were quantitated as in panel C. Neurite length was not statistically different between non-specific and A-Raf-
directed siRNA treatment (subpanel (i); P40.05, Mann–Whitney test), but was significantly reduced upon B-Raf and MEK2 knockdown
(Po0.0001 for both subpanels (ii) and (iii); Mann–Whitney test versus non-specific siRNA). (F, G) PC12 neuritogenesis stimulated by
transfection of activated (G12V) H-Ras (mean7s.e.m.: 42.172.8 mm) and activated (V600E) B-Raf (mean7s.e.m.: 40.672.6mm) is blunted by
RGS12 knockdown (mean7s.e.m.: 27.672.2 mm (F) and 27.371.8mm (G)). One hundred independent measurements of neurite length are
made for each treatment.
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et al, 1993). EGF acting through the EGF receptor induces
transient activation of ERK, resulting in proliferation (Huff
et al, 1981; Marshall, 1995). In contrast, NGF acting through
the TrkA receptor induces both transient and prolonged
phosphorylation of ERK, with the prolonged activation
required for differentiation (Qui and Green, 1992; Traverse
et al, 1992). We thus examined the effect of RGS12 knock-
down on ERK activation kinetics in PC12 cells stimulated
with NGF and EGF. Knockdown of RGS12 did not change
the levels of transient ERK activation (5–10 min) by NGF
(Figure 5A) or EGF (data not shown). However, the duration
of ERK activation upon NGF treatment was shortened by
RGS12 knockdown (Figure 5A), suggesting a mechanistic
explanation for the impairment in NGF-mediated neuritogen-
esis seen upon RGS12 depletion (Figure 4). Knockdown of
B-Raf and MEK2 levels, but not A-Raf levels, also leads to
a reduction in sustained ERK activation (e.g. Figure 5B;
120 min post-NGF treatment).
Subcellular localization of MAPK scaffolds, and the
proteins that they coordinate, is critical for their function
(Teis et al, 2002). We previously established that epitope-
tagged RGS12 localizes to intracellular puncta in primary
guinea-pig airway smooth muscle cells and regulates
PDGFbR trafficking and PDGF-mediated activation of the
MAPK cascade (Sambi et al, 2006). Similarly, in PC12 cells,
a YFP fusion of RGS12 localizes to punctate structures, in
comparison with YFP alone (Figure 5C). To determine
whether these puncta were endocytic vesicles, we stained
with early endosomal and late endosomal markers, EEA1
and LAMP1, respectively (Fukuda, 1991; Christoforidis
et al, 1999). RGS12-YFP showed colocalization with EEA1
(Figure 5D) as well as with LAMP1 (Figure 5E), suggesting
that overexpressed RGS12 is endosomal.
To explore the expression pattern of endogenous RGS12,
we used subcellular fractionation following NGF stimulation
of PC12 cells. Detection of RGS12 first occurs in the crude
membrane fraction (Figure 5F; 0 min), but RGS12 subse-
quently is enriched in both cytosolic and nuclear fractions
after NGF stimulation, with a concomitant decrease in the
membrane fraction (Figure 5F). We observed little change in
the localization or protein levels of nuclear and membrane
markers (lamin A/C and pan-cadherin, respectively; McKeon
et al, 1986; Takeichi et al, 1988), suggesting that the move-
ment of endogenous RGS12 from membrane to cytosolic and
nuclear fractions is specific.
RGS12 forms a multiprotein complex containing TrkA,
H-Ras, B-Raf, and MEK2
MAPK pathway scaffolds have been identified that promote
formation of stable complexes containing receptors
(Morrison and Davis, 2003; Kolch, 2005). For example,
b-arrestin-2 forms a complex with the angiotensin II type 1a
receptor and component kinases of the ERK MAPK cascade
(Luttrell et al, 2001). RGS12 interacts with activated H-Ras,
B-Raf, and MEK2 (Figures 1, 2, and 3), and appears to
regulate, and redistribute, upon NGF signaling in PC12 cells
(Figures 4 and 5). Thus, we hypothesized that RGS12 may
also associate with the primary NGF receptor in PC12 cells:
TrkA (Chao and Hempstead, 1995). Therefore, we transiently
expressed full-length RGS12 and TrkA in HEK 293T cells
and assayed for protein complex formation (Figure 6).
RGS12 co-immunoprecipitated with the TrkA receptor but
not with fibroblast growth factor receptor isoforms FGFR1
(Figure 6A) or FGFR2 (data not shown). Coexpression of
TrkA, but not FGFR1, redistributed YFP-RGS12 out of endo-
somes (Figure 6B and C), suggesting that RGS12 subcellular
localization is regulated specifically by TrkA. This subcellular
redistribution of YFP-RGS12 appears to be dependent on TrkA
kinase activity, given that kinase-inactive and kinase-domain-
deleted mutants of TrkA were unable to elicit redistribution;
furthermore, treatment with the TrkA inhibitor K-252a
(Berg et al, 1992) blocked RGS12 redistribution by wild-
type TrkA coexpression (Supplementary Figure S10). A multi-
protein complex containing RGS12, TrkA, activated H-Ras,
B-Raf, and MEK2 was detected by co-immunoprecipitation
(Figure 6D). These findings suggest that RGS12 associates
with TrkA and potentially tethers the Ras–Raf–MEK signaling
module to this receptor.
RGS12 receptor selectivity and role in axonal growth
of primary neurons
As an interaction between RGS12 and FGFRs was not de-
tected, we investigated whether RGS12 might selectively
regulate NGF-mediated but not bFGF-mediated signaling
in PC12 cells. bFGF can reproduce the entire spectrum of
PC12 cell responses known to be elicited by NGF, including
neurite outgrowth (Rydel and Greene, 1987). Whereas
RGS12 knockdown attenuated NGF-promoted neurite out-
growth (Figure 4), no significant change in neurite outgrowth
was seen with bFGF (Figure 6E). Consistent with this result,
no change in RGS12 subcellular localization was observed
upon stimulation with bFGF for up to 120 min (Figure 6F), in
contrast to the movement seen upon NGF stimulation
(Figure 5F). These data strongly suggest that RGS12 is critical
for NGF-mediated, but not bFGF-mediated, neurite outgrowth
and this may be due, at least in part, to a specific interaction
between RGS12 and the NGF receptor TrkA.
With our findings that RGS12 (i) forms a complex with
multiple proteins involved in the NGF-stimulated MAPK
signaling pathway, (ii) is critical for MAPK cascade-promoted
neuritogenesis in PC12 cells, and (iii) is expressed in trige-
minal and DRG neurons in the E14.5 embryonic mouse
(Martin-McCaffrey et al, 2005), we surmised that RGS12
may regulate a MAPK-mediated process in primary develop-
ing neurons. The Ras/Raf/ERK cascade is known to mediate
axon elongation in NGF-containing embryonic DRG cultures
(Liu and Snider, 2001; Markus et al, 2002; see also Atwal
et al, 2000). Expression of Ras and Raf dominant inhibitory
constructs strongly reduces NGF-induced axon growth from
dissociated cultures of embryonic DRG neurons, and over-
expression of activated H-Ras, Raf-1, or ERK leads to axonal
growth comparable to that elicited by NGF treatment (Markus
et al, 2002). Here, we found that siRNA knockdown of
mouse RGS12 (Figure 7A) leads to a significant reduction in
NGF-stimulated axonal growth in E14 DRG cultures from
both wild–type and Bax-null mice (Figure 7B–D).
Experiments were performed with Bax-null as well as wild-
type mice to exclude any effects of RGS12 inhibition on
neuronal survival.
Discussion
The Raf–MEK–ERK cascade is often depicted as a linear
signaling pathway traversing cytoplasm to connect receptor
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activation at the membrane with transcriptional effects in the
nucleus. However, regulation of this pathway is complex—
this kinase cascade lies downstream of various receptors and
is involved in many biological processes (Johnson and
Lapadat, 2002). Specificity in receptor-promoted signaling
to ERK activation and spatio-temporal regulation of these
signals are achieved by scaffolds. Several MAPK scaffolds
have now been identified, with Saccharomyces cerevisiae
Ste5 serving as the archetype, coordinating the kinases
Ste11 (MAP3K), Ste7 (MAP2K), and Fus3 (MAPK) for effi-
cient, pheromone-dependent activation of the MAPK cascade
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Figure 5 Prolonged ERK activation by NGF is reduced upon RGS12 depletion, expressed RGS12 is punctate and co-incident with endosomal
markers, and translocation of endogenous RGS12 from membranes is regulated by NGF. (A) PC12 cells were transfected with non-specific or
RGS12 siRNA and stimulated with NGF. ERK activation (pERK) and total ERK expression was determined by immunoblots (inset) with anti-
phospho-ERK1/2 or anti-ERK1/2 at indicated times after NGF treatment. Scion Image was used for densitometric quantitation of pERK1/2
levels and normalization to maximum signal (non-specific siRNA at 5 min). Error bars represent standard error of the mean from three
independent experiments. (B) Prolonged ERK activation is also reduced by siRNA-mediated knockdown of B-Raf and MEK2 levels, but not
A-Raf levels, in PC12 cells. Densitometric quantitation of pERK1/2 levels was normalized to maximum signal (non-specific (ns) siRNA at
120 min). (C) PC12 cells were transfected with pEYFP-N1 empty vector, YFP-RGS12, or RGS12-YFP vectors for 24 h, and treated with 100 ng/ml
NGF for an additional 48 h before epifluorescence imaging. (D, E) PC12 cells were transfected with RGS12-YFP (green) for 24 h, treated with
100 ng/ml NGF for an additional 48 h, fixed, permeabilized, and stained with early endosomal marker EEA1 (D, red) or late endosomal marker
LAMP1 (E, red) before confocal microscopy. Colocalization of RGS12-YFP and endosomal markers is shown in yellow. White arrows indicate
colocalization of RGS12-YFP with EEA1 or LAMP1 on individual puncta. (F) PC12 cells were stimulated with NGF at indicated time points, then
fractionated into membrane, cytosolic, nuclear, and cytoskeletal fractions as described in Materials and methods. Proteins resolved by SDS-
PAGE were immunoblotted with anti-RGS12, or antibodies against nuclear envelope marker lamin A/C or plasma membrane marker anti-pan-
cadherin.
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well-characterized ERK scaffold, kinase suppressor of Ras
(KSR), binds c-Raf-1, MEK1/2, ERK1/2, and other proteins
(Kolch, 2005), and is thought to be critical to Ras function,
given that KSR1-deficient fibroblasts are impaired in both
Ras-mediated ERK activation and cell transformation
(Kortum and Lewis, 2004). Our data suggest that RGS12,
analogous to these established functions of Ste5 and KSR,
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Figure 6 RGS12 forms a multiprotein complex containing TrkA and shows selectivity for TrkA signaling versus FGFR signaling. (A) HEK 293T
cells were cotransfected with myc-RGS12, and either empty vector, FLAG-TrkA, or HA-FGFR1 plasmids. Anti-FLAG or anti-HA antibody was
used to immunoprecipitate FLAG-TrkA or HA-FGFR1, respectively. Anti-myc was used to detect associated myc-RGS12 protein. (B) HEK 293T
cells were cotransfected with YFP-RGS12 and either (i) pcDNA3.1 empty vector, (ii) FLAG-TrkA, or (iii) HA-FGFR1 vectors and imaged
by confocal microscopy; scale bar represents 20 mm. (C) HEK 293T cells were transfected as described in panel B. At 72 h post-transfection,
cells were lysed and immunoblotted to verify expression of YFP-RGS12, FLAG-TrkA, and HA-FGFR1. (D) HEK 293T cells were transfected
with myc-RGS12, FLAG-TrkA, HA-B-Raf, HA-MEK2, and HA-H-Ras G12V plasmids. Lysates were immunoprecipitated with beads alone or anti-
FLAG antibody. Anti-HA and anti-myc were used to detect associated myc-RGS12, HA-B-Raf, HA-MEK2, and HA-H-Ras G12V. (E) PC12 cells
were transfected with non-specific or RGS12 siRNA for 24 h and treated with 100 ng/ml bFGF for an additional 48 h. Differences in neurite
length were quantitated as described in Figure 4C. Median neurite lengths of non-specific siRNA-transfected cells were not significantly
different from those of RGS12 siRNA-transfected cells (P40.03; Mann–Whitney test). (F) PC12 cells were stimulated with bFGF for the
indicated durations. Cells were then fractionated into membrane, cytosolic, nuclear, and cytoskeletal fractions as in Figure 5F. Proteins resolved
by SDS–PAGE were immunoblotted with anti-RGS12, or antibodies against nuclear envelope marker lamin A/C or plasma membrane marker
anti-pan-cadherin.
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primary neurons by forming a signaling complex containing
TrkA, H-Ras, B-Raf, MEK2, and ERK proteins.
MAPK scaffolds not only tether proteins together, but also
specify their subcellular localization and guide their ultimate
output. In tethering Ste11, Ste7, and Fus3 through indepen-
dent binding sites (Choi et al, 1994), Ste5 recruits these
kinases to the plasma membrane—the site at which upstream
proteins participate in pheromone-dependent activation
of the MAPK cascade (Pryciak and Huntress, 1998). In this
way, Ste5 not only increases MAPK signaling efficiency, but
also generates specificity by insulating the pheromone res-
ponse from other parallel pathways (nutritional cues and
osmotic stress), which use some or all of these same signaling
components (Elion, 2001). The ubiquity of these signaling
components is even more dramatic in mammalian cells, as
underscored by the fact that over 160 substrates for the final-
tier kinases ERK1/2 have now been described. The majority
of these ERK substrates are nuclear; however, numerous
others exist in the cytosol and at other organelles, including
endosomes (Roux and Blenis, 2004; Yoon and Seger, 2006).
Scaffold-mediated regulation of the utilization of particular
MAPK substrates contributes to the distinct, and at times
opposing, cellular events regulated by the ubiquitous MAPK
cascade. In this context, our results provide several lines
of evidence that RGS12 is a selective scaffold regulating
prolonged ERK activation downstream of particular inputs
and components: for example, NGF versus bFGF, activated
H-Ras versus related GTPases, and B-Raf versus c-Raf-1.
In contrast to its robust association with activated H-Ras,
RGS12 did not bind appreciably to other Ras isoforms. As
H-, N-, and K-Ras are highly homologous, it is likely that
their unique hypervariable linker domain sequences and
differential post-translational modifications, known to se-
quester these Ras family members to distinct cellular locales
(Ashery et al, 2006), may dictate, in part, the functional
differences seen among Ras isoforms for RGS12 association.
Ras signaling from internal membrane compartments is well
documented, with one well-described mechanism involving
endocytosis (Jiang and Sorkin, 2002), whereby EGF promotes
internalization of active H-Ras, EGFR, and Ras effectors into
endosomes. Similarly, the scaffold protein MP1, which binds
to MEK1 and enhances ERK1 activation, localizes EGF-pro-
moted Ras/MAPK signaling to late endosomes (Teis et al,
2002); MP1 is dispensable for transient EGFR activation of
ERK at the plasma membrane, but essential for delayed
activation of ERK on late endosomes. The enhancement of
MAPK activation by MP1 is strictly dependent on the endo-
somal localization of the complex, as the artificial mislocali-
zation of MP1 to the plasma membrane abolishes its positive
effect. Thus, compartmentalizing Ras at endosomes appears
to provide a means for trafficking and promoting MAPK
signaling. These results, and our findings that RGS12 loca-
lizes to endocytic vesicles and binds multiple MAPK cascade
components in addition to activated H-Ras, suggest that
RGS12 may be a novel endosomal Ras effector scaffold.
In PC12 cells, transient ERK activation promotes cell
proliferation, whereas prolonged ERK activation promotes
neuronal differentiation (Heasley and Johnson, 1992;
Traverse et al, 1992; Nguyen et al, 1993; Marshall, 1995).
























































Figure 7 RGS12 is critical for NGF-mediated axonal growth in primary mouse DRG neurons. (A) N1E-115 mouse neuroblastoma cells were
transfected with non-specific or mouse RGS12-directed siRNA and lysed 72 h post-transection for immunoblotting of RGS12 and actin. (B)
Wild-type mouse embryo (E14) DRG neurons were transfected with non-specific or mouse RGS12 siRNA (along with YFP tracer), cultured for 2
days with NGF (50 ng/ml), replated, and stimulated with NGF for 1 day. Axons of YFP-positive cells were traced in camera lucida and
quantitated using IPlab. RGS12 knockdown resulted in a significant decrease in longest axonal length (Po0.0001; Mann–Whitney test). (C)
Bax-deficient mouse E14 DRG neurons were transfected as in panel B, cultured without NGF for 2 days, and stimulated with NGF (50 ng/ml)
for 36 h. Axonal length of YFP-positive cells was quantitated as in panel B. RGS12 knockdown resulted in a significant decrease in longest
axonal length (Po0.0001; Mann–Whitney test). (D) Photomicrographs of representative wild-type DRG neurons transfected with non-specific
(left) or mouse RGS12 (right) siRNA. Cell bodies are denoted with gray arrowheads; scale bar represents 100 mm.
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components appears to be critical for these differences,
suggesting that endosomes may serve as the sites that
generate persistent, rather than transient, signaling through
Ras. Here, we show that RGS12 localizes to endosomes and
its depletion attenuates prolonged ERK activation and neuro-
nal differentiation. Proteins involved in NGF-mediated neur-
ite outgrowth are known to localize to endosomes, and this
localization is critical for their participation in neuronal
differentiation of PC12 cells (Zhang et al, 2000; Howe et al,
2001). Isolated clathrin-coated vesicles from NGF-treated
PC12 cells were found to contain NGF bound to TrkA together
with activated signaling proteins of the Ras/MAPK pathway
(Howe et al, 2001). Additionally, neuronal differentiation is
stimulated by catalytically active Trk receptors specifically
trafficked to endocytic vesicles; if NGF internalization in
PC12 cells is inhibited by dominant-negative dynamin, neur-
ite outgrowth is blunted (Zhang et al, 2000). These results
suggest that RGS12, by binding TrkA and components of the
Ras/MAPK cascade, might serve to coordinate this endoso-
mal MAPK signaling required for prolonged ERK activation
and neuritogenesis.
The most compelling context for this new data regarding
RGS12 as a putative endosomal scaffold for TrkA-activated
MAPK signaling is in the known response of primary neurons
to trophic factors. NGF signals through TrkA to promote
differentiation, survival, and maintenance of primary neu-
rons (Casaccia-Bonnefil et al, 1999; Sofroniew et al, 2001).
For neurotrophins to induce these pleiotropic effects, the
signal must be communicated from axon terminals to cell
bodies. One hypothesis suggests that ‘signaling endosomes’
containing NGF-bound TrkA are formed at the axon terminal
and traffic in a retrograde manner to the cell body, where
they initiate local signal transduction cascades (Howe and
Mobley, 2004); such retrograde transport and signaling of
neurotrophins like NGF is thought to be critical to the
development and maintenance of the nervous system
(Sofroniew et al, 2001). NGF-containing vesicles transported
retrogradely contain active components of the ERK pathway
in vivo (Johanson et al, 1995). Thus, it is possible that RGS12
represents a key component of the NGF-derived signaling
endosome.
In addition to their originally described roles as Ga GAPs
and negative regulators of GPCR signaling, RGS proteins
increasingly appear as scaffolds that integrate signaling
from diverse receptors and steer pathway output to divergent
cytoplasmic signaling networks (Siderovski and Willard,
2005). Our observation that RGS12 preferentially binds to
activated H-Ras is in line with yeast two-hybrid data that
Loco (the fly ortholog) interacts with Drosophila Ras1
(Formstecher et al, 2005), suggesting that RGS12 might
constitute an evolutionarily conserved molecular link that
integrates receptor tyrosine kinase signaling with GPCR
signaling in both vertebrates and invertebrates. Interes-
tingly, Loco localization in surface glia is punctate throughout
the cytosol (Schwabe et al, 2005), similar to RGS12 in PC12
cells, HEK 293T cells, primary airway smooth muscle cells,
and primary DRG neurons (this report, Sambi et al, 2006, and
unpublished results). Although the mechanism by which
RGS12 localizes to endosomes is unknown, it is possible
that the Gai-binding C-terminal GoLoco motif plays a role; we
have previously reported that a loss-of-function mutation in
the GoLoco motif mislocalizes RGS12 to the nucleus (Sambi
et al, 2006). Thus, the multiple functional domains within
RGS12 may cooperate to define the spatial and temporal
nature of an RGS12-coordinated signaling output initiated
from receptor tyrosine kinases and both monomeric and
heterotrimeric G-protein subunits. Our observation that
reducing RGS12 expression is able to blunt the actions of
oncogenic alleles of H-Ras and B-Raf highlights the impor-
tance of future investigations into RGS12 functions in
transformation-promoting MAPK signal transduction beyond
that of NGF-mediated axonal growth.
Materials and methods
Biological reagents and cellular assays
A list of plasmids, antibodies, agonists, and other biological
materials used, as well as routine procedures for cell culturing,
transient transfection of plasmid DNA, cell imaging by confocal
microscopy, harvesting of cell lysates, subcellular fractionation,
immunoprecipitation, and immunoblotting are described in the
Supplementary data.
siRNA transfection
siRNAs against rat A-Raf, B-Raf, MEK2, and RGS12 (the latter
including SMARTpool and constituent individual duplexes) were
from Dharmacon (Lafayette, CO). Non-specific siRNA (50-CUAC-
GUCCAGGAGCGCACC-30) was used as a negative control (Gulla-
palli et al, 2006). PC12 cells were plated the day before transfection
at 130 000 or 260 000 per well in 12-well culture dishes coated with
poly-D-lysine (BD Biocoat, Franklin Lakes, NJ) and transfected with
150 nM siRNA using Lipofectamine 2000 (L2K; Invitrogen) accord-
ing to the manufacturer’s protocol. N1E-115 cells were plated
the day before transfection at 50 000 cells per well in a 12-well
culture dish and transfected using L2K with 150 nM mouse RGS12
SMARTpool siRNA (Dharmacon).
PC12 differentiation
PC12 cells were transfected with non-specific or RGS12 siRNA for
24 h and treated with 100 ng/ml NGF or bFGF (in 1% serum) for an
additional 48 h. Brightfield images were obtained using an Olympus
IX70 with a Q-Fire CCD camera. To quantitate differences in neurite
length, 4100 cells were counted per condition in three independent
experiments using the ImageJ Measure feature (http://rsb.info.-
nih.gov/ij/); length was converted into micrometer and analyzed
for statistical significance using Prism 4.0 (GraphPad, San Diego,
CA).
Transfection and imaging of primary neurons
Isolation, culture, transfection, and imaging of wild-type and Bax-
null mouse embryonic DRG (embryonic day 14) were performed as
described (Kim et al, 2006), with the following modifications: DRG
neuron cultures were coelectroporated with siRNA and YFP tracer
DNA (pCS2-Venus; 3 mg) and subsequently stained with GFP
antibody (A11122; Invitrogen) to highlight axon morphology.
Quantitative determinations of axon length were based on analyses
of 4100 transfected neurons each in the non-specific and RGS12
siRNA-transfected cultures.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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